Initial evaluation of PET/CT with (18)F‐FSU‐880 targeting prostate‐specific membrane antigen in prostate cancer patients

This first‐in‐man study was carried out to evaluate the safety, whole‐body distribution, dose estimation, and lesion accumulation of (18)F‐FSU‐880, a newly developed probe targeting prostate‐specific membrane antigen. Six prostate cancer patients with known metastatic lesions underwent serial whole‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Saga, Tsuneo, Nakamoto, Yuji, Ishimori, Takayoshi, Inoue, Takahiro, Shimizu, Yoichi, Kimura, Hiroyuki, Akamatsu, Shusuke, Goto, Takayuki, Watanabe, Hiroyuki, Kitaguchi, Kosuke, Watanabe, Masao, Ono, Masahiro, Saji, Hideo, Ogawa, Osamu, Togashi, Kaori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361557/
https://www.ncbi.nlm.nih.gov/pubmed/30549183
http://dx.doi.org/10.1111/cas.13911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361557/
https://www.ncbi.nlm.nih.gov/pubmed/30549183
http://dx.doi.org/10.1111/cas.13911

Ejemplares similares